Emerging Implantable-Device Technology for Patients at the Intersection of Electrophysiology and Heart Failure Interdisciplinary Care
Key result
Emerging cardiac implantable electronic devices, including cardiac contractility modulation and baroreflex activation therapy, offer potential benefits for patients with heart failure.
Why the study?
Recent technological advancements in cardiac implantable electronic devices and emerging technologies offer new monitoring and therapeutic options, requiring description of their mechanisms, clinical roles, and interdisciplinary management.
Design
State-of-the-art review
Authors
Discussion
Loading...
Member takes
Implication
Warrants consideration in select advanced HF patients; extends device options beyond CRT and ICDs.
Structured PICO
P
Population
Patients with heart failure with reduced ejection fraction (HFrEF) and those without indications for cardiac resynchronization
I
Intervention
Emerging implantable-device technologies including algorithmic multiparameter remote monitoring, cardiac contractility modulation, and baroreflex activation therapy
Emerging implantable device technologies offer new physiological monitoring and therapeutic options for heart failure patients, requiring close interdisciplinary management between electrophysiology and heart failure specialists.
Cite This Study
Mastoris et al. (2021) conducted a review in Heart failure with reduced ejection fraction. Cardiac implantable electronic devices was evaluated. Emerging cardiac implantable electronic devices, including cardiac contractility modulation and baroreflex activation therapy, offer potential benefits for patients with heart failure.